Work

Pdb25 Cost-effectivenes of Real-world Use of Glp-1 Receptor Agonists Versus Other Glucose-lowering Agents in Type 2 Diabetes

Year: 2020

Type: conference-abstract

Source: Value in Health

DOI: 10.1016/j.jval.2020.04.213

Authors: C.Y. Yang, Y.R. Chen, C. Yang, S. Kuo, H.T. Ou

Institutions: National Cheng Kung University, University of Michigan, Michigan Medicine

Language: English

Topic: Diabetes Treatment and Management

Subfield: Endocrinology, Diabetes and Metabolism

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W3027895333

Cites:

Cited by:

Related to: 10